Status:

COMPLETED

Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer

Lead Sponsor:

Fundacion Dexeus

Conditions:

Infertility

Preimplantation Genetic Diagnosis/Screening

Eligibility:

FEMALE

18-43 years

Brief Summary

The development and improvement in Preimplantation genetic diagnosis/screening (PGS) in association with the efficacy and security of vitrification and trophectoderm biopsy, more efficient stimulation...

Eligibility Criteria

Inclusion

  • Frozen embryo transfer (FET) of at least one single euploid embryo.
  • Estradiol \> 75pg/ml.
  • Progesterone \> 4 ng/ml.
  • Endometrial thickness between 6 mm and 18 mm.

Exclusion

  • Patients with FET of no diagnostic or mosaic embryos, or known uterine abnormality were excluded.
  • Natura cycle protocol.

Key Trial Info

Start Date :

January 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2018

Estimated Enrollment :

299 Patients enrolled

Trial Details

Trial ID

NCT03395665

Start Date

January 1 2014

End Date

January 1 2018

Last Update

February 28 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Obstetrics, Gynaecology and Reproduction Instituto Universitario Dexeus

Barcelona, Spain, 08028

Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer | DecenTrialz